Heidi A. Erickson, Ph.D. - Publications
Affiliations: | 2004 | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Molecular Biology, Immunology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Tyner JW, Deininger MW, Loriaux MM, Chang BH, Gotlib JR, Willis SG, Erickson H, Kovacsovics T, O'Hare T, Heinrich MC, Druker BJ. RNAi screen for rapid therapeutic target identification in leukemia patients. Proceedings of the National Academy of Sciences of the United States of America. 106: 8695-700. PMID 19433805 DOI: 10.1073/Pnas.0903233106 | 0.374 | |||
2008 | Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loriaux M, Erickson H, Corbin AS, O'Hare T, Heinrich MC, Deininger MW, Druker BJ. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood. 111: 2238-45. PMID 18025156 DOI: 10.1182/Blood-2007-06-097253 | 0.339 | |||
2006 | Erickson HA, Jund MD, Pennell CA. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition. Protein Engineering, Design & Selection : Peds. 19: 37-45. PMID 16243897 DOI: 10.1093/Protein/Gzi073 | 0.492 | |||
2002 | Pennell CA, Erickson HA. Designing immunotoxins for cancer therapy. Immunologic Research. 25: 177-91. PMID 11999171 DOI: 10.1385/Ir:25:2:177 | 0.479 | |||
2001 | Erickson HA, Reinhardt RL, Hermanson JB, Panoskaltsis-Mortari A, Pennell CA. Visualization of immunotoxin-mediated tumor cell death in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 890s-894s. PMID 11300488 | 0.472 | |||
Show low-probability matches. |